Breast cancer survivors may have lower risk of developing Alzheimer's disease, study finds
A study led by the Seoul National University College of Medicine suggests that breast cancer survivors could have a slightly lower chance of developing Alzheimer's disease compared to those who had not undergone treatment.
In the study, which was published in JAMA Network Open, data from more than 70,000 breast cancer survivors were compared to a cancer-free control group for an average of 7.3 years.
FDA APPROVES FIRST AI TOOL TO PREDICT BREAST CANCER RISK
Overall, the breast cancer survivors — particularly those who were 65 and older — showed an 8% lower risk of dementia within the five years following treatment.
Those who received radiation showed the most risk reduction, the researchers found.
The study was adjusted for other factors that could have contributed to Alzheimer's risk, including age, income levels, geographic location, body mass index, comorbidities (diabetes, hypertension, high cholesterol and chronic kidney disease) and health-related behaviors (smoking, alcohol consumption and physical activity), the study stated.
This outcome conflicts with previous concerns about breast cancer patients experiencing cognitive decline after treatment.
BILL GATES REVEALS 'NEXT PHASE OF ALZHEIMER'S FIGHT' AS HE SHARES DAD'S PERSONAL BATTLE
Chemotherapy has previously been linked to a condition called "chemo brain," where patients experience cognitive decline.
"Chemo brain refers to cognitive dysfunction, including thinking and memory problems, that occur in patients with cancer during and after chemotherapy," the researchers wrote.
RATES OF DEMENTIA ARE LOWER IN PEOPLE WHO EAT THIS SPECIFIC DIET, RESEARCH SHOWS
This is different from Alzheimer's, however — with "chemo brain," the cognitive impairment is described as "subtle" and doesn't keep the patient from retrieving remote memories.
"Concerns about chemo brain and the long-term adverse effects of breast cancer treatment on cognition are common, but our findings suggest that this treatment does not directly lead to AD," the researchers noted.
In fact, they stated, some studies have shown that certain drugs given to breast cancer patients can help to reduce the formation of amyloid-beta and tau proteins in the brain, which is one of the hallmarks of Alzheimer's.
Based on the findings, the researchers recommend that breast cancer patients take steps to reduce modifiable risk factors for Alzheimer's, such as smoking and diabetes, along with receiving standard cancer treatment. Study limitations
The study did have some limitations, the team acknowledged.
Information about patients' breast cancer stage and radiation dose was not available. It is also possible that the number of Alzheimer's diagnoses was underestimated.
Also, because the study focused on patients with "operable" breast cancer, it may not represent the risk of Alzheimer's among elderly patients, those with "critical comorbidities" or patients with advanced-stage disease, the researchers noted.
CLICK HERE TO GET THE FOX NEWS APP
"We could not evaluate the long-term increase in AD risk because our follow-up period was relatively short (maximum, 11 years)," they wrote.
"Additional studies with long-term observation periods are warranted to examine long-term associations between AD risk and breast cancer survival duration."
Maria C. Carrillo, Ph.D., Alzheimer's Association chief science officer and medical affairs lead in Chicago, pointed out that this topic of research has been explored in previous studies.
"There have been many published reports from observational studies of cancer survivors with decreased risk of Alzheimer's disease, but also some that found increased risk," Carrillo, who was not involved in this most recent study, told Fox News Digital.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The expert cautions against drawing "abrupt conclusions" based on this study.
"Previous research on cancer survival and treatment and Alzheimer's risk, much of it cited by the authors of this article, has produced mixed — even contradictory — results," Carrollio said. "More research is needed — especially longer studies in more representative study populations."
The most interesting aspect of this study, Carrillo said, is the finding that radiation therapy was associated with 23% Alzheimer's risk reduction, while other cancer treatments showed no risk reduction.
This could be due to radiation's capability to lower inflammation levels, the expert suggested.
For more Health articles, visit www.foxnews.com/health
"Lowering inflammation in the body and brain can reduce amyloid beta or slow amyloid beta production, delaying the onset of symptomatic Alzheimer's," she said. "More research is needed to see if this is, in fact, the case."
Approximately 7.2 million Americans aged 65 and older are currently living with Alzheimer's, according to the Alzheimer's Association.
Fox News Digital reached out to the study researchers for comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Divamics' AI and Molecular Dynamics Platform Powers Breakthroughs in Metabolic Disease Drug Discovery for Partners
SUZHOU, China, July 15, 2025 /PRNewswire/ -- Divamics, a pioneer in AI-driven drug discovery, highlighted its critical role in advancing metabolic disease therapeutics through its advanced AI and molecular dynamics(MD) platform. This powerful platform recently supported the successful design of BGM1812, a novel dual AMY3R/CTR receptor agonist for obesity treatment, as published in the July 2025 issue of the Journal of Medicinal Chemistry. This achievement underscores Divamics' consistent ability to empower its partners in accelerating their drug discovery pipelines. AI-Powered Efficiency & Precision in Collaborative Drug Discovery Divamics' platform proved instrumental in optimizing peptide interactions to achieve superior receptor binding for BGM1812. Preclinical studies demonstrated that BGM1812 achieved an optimized in vitro potency, registering a 50% increase in effect, alongside superior in vivo efficacy, including significant weight loss and an improved metabolic profile. Mechanistic Breakthroughs Enabled by Divamics' AI and Molecular Dynamics Divamics' platform enables a deep, mechanistic understanding of drug-receptor interactions at an atomic level. For instance, the mutation of Ile(Me)24 to Gly(Me)24 led to enhanced anti-aggregation properties. Further AI-guided MD simulations revealed how hydrophobic residues form a crucial "hydrophobic cage" with receptor, stabilizing the molecule. Strategic alpha-carbon methylation of these residues, precisely guided by Divamics' AI, ultimately yielded BGM1812, showcasing the platform's capacity to pinpoint and validate subtle yet critical structural enhancements that drive therapeutic efficacy for collaborative projects. Validated Track Record in Empowering Drug Discovery With its instrumental contribution to two successful candidates—BGM1812 and BGM0504 (in Phase III clinical trials since 2024)—Divamics' AI and molecular dynamics technology has proven its deep expertise in supporting the advancement of metabolic disease therapeutics. The iterative success in these collaborative projects highlights the platform's potential to re-imagine drug discovery, enabling partners to deliver high-quality leads with unprecedented efficiency. "Our collaboration with partners like Brightgene, leading to the publication of BGM1812 in the Journal of Medicinal Chemistry and the advancement of BGM0504 into Phase III, establishes Divamics' AI and MD platform as a powerful engine for drug discovery in metabolic disease," said Dr. John Zheng, CEO of Divamics. "The consistent success our technology brings to these collaborative efforts is not just accelerating the pace of discovery; it's redefining how our partners can approach previously 'undruggable' targets and bring high-potential therapeutic leads to the clinic." Divamics remains committed to providing its cutting-edge AI and MD capabilities to advance the global drug development landscape. Reference View original content to download multimedia: SOURCE Divamics Inc. Sign in to access your portfolio
Yahoo
5 hours ago
- Yahoo
Less aggressive treatment for low-risk breast cancer ‘just as effective'
More targeted and less aggressive radiotherapy for low-risk breast cancer could spare thousands of women from the harsh side-effects of the treatment, a trial has found. The technique, which has since been adopted by the NHS, has 'transformed' the way the disease is treated in its early stages, researchers said. More than 37,000 women have radiotherapy for breast cancer in the UK every year. The treatment uses radiation to kill cancer cells and is usually given after surgery to reduce the risk of the disease coming back. However, side-effects can include changes in breast size and shape, swelling in the arms or breast, and pain. The Import Low trial, led by The Institute of Cancer Research, London, and the University of Cambridge, found limiting radiation to the tumour area, rather than treating the whole breast, was just as effective. The study included 2,018 women across 30 radiotherapy centres in the UK, who were monitored for 10 years after treatment. It compared three radiotherapy approaches; whole-breast, partial-breast and a reduced-dose. After a decade, cancer recurrence rates in the group given partial radiotherapy was 3%, the same proportion as those who had been treated with a more aggressive approach. Patients who had targeted radiotherapy were also less likely to experience long-term changes in breast appearance. Some 15% reported noticeable changes at five years compared with 27% in the whole-breast radiotherapy group. Dr Anna Kirby, consultant clinical oncologist at The Royal Marsden NHS Foundation Trust, and reader in breast cancer radiotherapy at The Institute of Cancer Research, London, said: 'The long-term results of this study confirm that a less aggressive approach, limiting radiotherapy to the tumour rather than the whole breast, is just as effective as traditional whole-breast radiotherapy. 'Patients receiving partial-breast radiotherapy experience fewer side-effects while maintaining excellent cancer control.' Charlotte Coles, a professor of breast cancer clinical oncology at the University of Cambridge, honorary clinical oncology consultant at Cambridge University Hospitals NHS Foundation Trust, and chief investigator of the Import Low study, said the trial has 'transformed' how early breast cancer is treated. Following the study, which is published in the Lancet Oncology, partial-breast radiotherapy has been integrated into NHS treatment guidelines. It is hoped that more than 9,000 women in the UK could benefit from more targeted treatment. 'By targeting the area around the tumour, rather than the whole breast, we have demonstrated that patients can achieve the same outstanding long-term outcomes with fewer complications,' Prof Coles said. 'This approach is now widely adopted across the NHS, sparing thousands of women from unnecessary radiation exposure. 'The results of this study have not only shaped UK clinical practice but also informed international guidelines, ensuring that women worldwide benefit from this personalised, evidence-based treatment.' Hilary Stobart, now 70, was diagnosed with ER-positive breast cancer in December 2008, with a 2cm tumour in her left breast. Ms Stobart, who was 54 at the time, was offered the chance to take part in the trial after surgery and was treated with partial radiotherapy. 'I had three weeks of radiotherapy, but suffered no side-effects, other than some soreness in my breast and nipple in the first few weeks,' she said. 'Ten years on, I am doing fine. I have no side-effects and no recurrence of disease. 'For me personally, I am very thankful to have received the lowest dose of radiotherapy. 'Whilst I may have had some niggling worries in the early days, having seen the results of the trial, I feel positive and optimistic now. I know that I was lucky enough back then to have had the best treatment, a treatment that other women will be routinely offered now.' Dr Fay Cafferty, lead statistician at The Institute of Cancer Research, London, added that the findings are 'crucial in reinforcing the long-term safety and effectiveness of partial-breast radiotherapy'. 'Long-term data is vital to ensure we know there's no greater risk of breast cancer returning after this targeted radiotherapy treatment,' she said. 'This latest analysis confirms that partial breast radiotherapy remains a safe and effective treatment option, supporting its continued adoption as the standard of care in the UK and globally.'
Yahoo
5 hours ago
- Yahoo
Brown Rice vs. White Rice: Nutrition Experts Reveal Which Is Actually Better for You
Brown rice packs more fiber and nutrients than white rice, supporting gut health, stable energy, and overall wellness. White rice digests faster and spikes blood sugar more, but can still fit into a healthy diet when paired with fiber- or protein-rich foods. Though it has a slightly different taste and texture, brown rice can be an easy, nutritious swap for white rice in many has been a culinary staple for thousands of years across cultures all over the world, especially in countries like China, India, Japan, and South Korea. But this grain's popularity has since gone global with this grain taking up permanent residence in many pantries across America. Historically, white rice has been the traditional choice, however, brown rice has become a go-to choice as well, with particular thanks to its reputation for having more health benefits than white rice. But what are the nutritional advantages of brown rice compared to white rice? How do white and brown rice differ from one another, and how do those differences impact our health (if at all)? Is it really 'healthier' to swap white rice for brown rice when ordering takeout or deciding what to make for dinner? It's time to unpack all your burning rice nutrition questions. Related: A Guide to the 10 Best Types of Rice, and How to Cook With Them How do these rice relatives differ on a physical and nutritional basis? 'Physically, white rice contains just one part of the usual rice grain anatomy due to a refining process that removes two key parts of whole rice grain,' explains clinical dietitian Caitlin Carr, MS, RD. Whole grains, including whole rice grains (aka brown rice), consist of three structures, or layers—the bran, germ, and endosperm. White rice is made by stripping the bran and germ from brown rice leaving behind its starchy core, the endosperm. This yields some important nutritional differences between the two rice varieties. In two-thirds of a cup, brown rice contains about two grams of fiber whereas white rice contains only about 0.5 grams. Additionally, 'brown rice has more essential minerals like manganese, phosphorus, selenium, and magnesium, along with B-vitamins such as niacin and folate when compared, per cup, to white rice,' Carr says. Brown rice is also a good source of plant compounds like flavonoids. These additional phytonutrients found in brown rice help to support better gut, bone, heart, immune, and metabolic health. 'Because of its fiber content, brown rice is a complex carbohydrate, while white rice is a simple carbohydrate. This means that brown rice takes a little longer to digest than white rice,' Carr explains. The increased digestion time of brown rice provides more stable energy levels and also has a positive impact on blood sugars through a more gradual rise and decline in sugar levels. This benefit is particularly significant for those with metabolic concerns like type 2 diabetes, as it can make blood sugar management easier. 'Brown rice also contains soluble fiber, which is beneficial for maintaining bowel regularity, lowering cholesterol levels, and feeding our gut microbiome,' Carr says. 'When the microorganisms in the gut microbiome metabolize soluble fiber, they produce short-chain fatty acids that are absorbed by the gut lining, beginning a cascade of events that are suggested to lower inflammation and oxidative stress throughout the body.' This benefit is part of the reason why a thriving gut microbiome is linked to better immune, gut, and brain health, among other impressive benefits. As we've already started to see, white rice doesn't quite measure up nutritionally to brown rice due it's lower fiber and micronutrient content. White rice's lower fiber content also equates to a higher score on the glycemic index, a scale to measure how quickly a given food will elevate blood sugars. This index ranks foods on a scale of zero to 100, where the higher the score, the more rapidly a food gets digested in the body, and the more quickly our blood sugars spike. As a refined, or simple, carbohydrate, white rice has a glycemic index of 70 while brown rice measures in at 50. Because of this, very frequent white rice consumption may put us at increased risk for type 2 diabetes, per a 2019 review. This is not to say, however, that white rice can't be part of a balanced, healthy diet—especially when it's eaten accompanied by healthy, high-fiber and high-protein sources. 'Brown and white rice are both naturally gluten-free and low-FODMAP foods,' Carr notes, 'For individuals with celiac and/or trialing a temporary elimination diet for irritable bowel syndrome (IBS), rice [of either variety] may be a good carbohydrate option to include in their meal plans.' The eating experience between these two grains is similar, and they're typically easy to substitute for one another—however, there are some notable differences. White rice tends to offer a softer texture and more neutral, mild taste. Brown rice, on the other hand, has a chewier texture and nuttier flavor. These differences can take some getting used to if white rice has always been your go-to, but that doesn't preclude brown rice from being an equally delicious swap-out for white rice in most recipes. White rice is a delicious, traditional, and nostalgic comfort food for many of us, but when you dig into the nutritional details, there's no denying that brown rice has a leg up in terms of beneficial fiber, micronutrients, and plant compounds. And while white rice enjoyed in moderation can still fit into a healthy, balanced lifestyle, substituting it for brown rice every so often can definitely provide in some wholesome benefits. 'I love that both white and brown rice are affordable sources of carbohydrates that can be utilized in so many dishes, made in batches, and stored easily,' Carr says. Some tasty ways to enjoy rice, both white or brown, include stir-fries, fried rice, sushi, curry, rice and beans, rice pilaf, jambalaya, baked rice, soups, chicken and rice dishes, and stews. Related: The 15 Healthiest Grains to Eat, According to a Nutrition Expert Read the original article on Real Simple
